Barrigel rectal spacer aims to protect the rectum during radiation therapy for prostate cancer, with FDA clearance for T1-T3b cases. The PPRT trial is the first to include patients with recurrent ...

The product is indicated for patients with T1-T3b prostate cancer. These studies provide additional evidence supporting the use of Barrigel™ in routine clinical practice, with its ability to be ...

Barrigel™, which is approved for use in the United States, Australia, and Europe, offers a significant reduction in unwanted side effects from prostate cancer radiation therapy. The product is ...

Prostate cancer is frequently seen as an area of low ... or into the seminal vesicles (T3b). A number of subtle signs of extracapsular spread are also described, including loss of the ...

• Barrigel™ rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and ...

Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in a new clinical study focused on the ...